Table.

Characteristics of patients.

	Total (n = 53)
Age	45 (18–68)
Sex MaleFemale	29 (54.7%)24 (45.3%)
DiagnosisHLNHLDLBCLMCLFLT-rich B-cell lymphomaT-cell lymphomaGray zone lymphomaAnaplastic large cell lymphomaBurkitt lymphomaEBV-associated B-cell lymphomaMarginal to DLBCL	14 (26.4%)39 (73.6%)18 (33.9%)6 (11.3%)4 (7.5%)2 (3.7%)3 (5.6%)2 (3.7%)1 (1.9%)1 (1.9%)1 (1.9%)1 (1.9%)
Remission duration prior to salvage (n = 46)*Primary refractoryEarly relapse (≤12 months)Late relapse (>12 months)	5 (9.4%)22 (41.5%)19 (35.8%)
Salvage regimen (n = 46)*R±ICER±DHAPBEACOPPFCMR+GDPR±CHOPR-DHAP/R-Bendamustin	32 (69.5%)9 (19.5%)1 (2.2%)1 (2.2%)1 (2.2%)1 (2.2%)1 (2.2%)
Assessment pre-ASCTCRPRStable (refractory) diseaseProgressive disease	20 (37.7%)24 (45.3%)4 (7.5%)5 (9.5%)